Cellular fatty acid-deficient Pandoraea isolated from a patient with cystic fibrosis

References

1. Coenye, T., Falsen, E., Hoste, B., Ohlen, M., Goris, J., Govan, J. R., Gillis, M. & Vandamme, P. ( 2000; ). Description of Pandoraea gen. nov. with Pandoraea apista sp. nov., Pandoraea pulmonica sp. nov., Pandoraea sputurum sp. nov., and Pandoraea norimbergensis comb. nov. Int J Syst Evol Microbiol 50, 887–899.[CrossRef]
   [Google Scholar]
2. Daneshvar, M. I., Hollis, D., Steigerwalt, A. G., Whitney, A. M., Spangler, L., Douglas, M. P., Jordan, J. G., MacGregor, J. P., Hill, B. C. & other authors ( 2001; ). Assignment of CDC weak oxidizer group 2 (WO-2) to the genus Pandoraea and characterisation of three new Pandoraea genomospecies. J Clin Microbiol 39, 1819–1826.[CrossRef]
   [Google Scholar]
3. Krejči, E. & Kroppenstedt, R. ( 2006; ). Differentiation of species combined into Burkholderia cepacia complex and related taxa on the basis of their fatty acid patterns. J Clin Microbiol 44, 1159–1164.[CrossRef]
   [Google Scholar]
4. Moore, J. E., Reid, A., Millar, B. C., Jiru, X., Mccaughan, J., Goldsmith, C. E., Collins, J., Murphy, P. G. & Elborn, J. S. ( 2002; ). Pandoraea apista isolated from a patient with cystic fibrosis: problems associated with laboratory identification. Br J Biomed Sci 59, 164–166.
   [Google Scholar]
5. Segonds, C., Paute, S. & Chabanon, G. ( 2003; ). Use of amplified DNA restriction analysis for identification of Ralstonia and Pandoraea species: interest in determination of the respiratory bacterial flora in patients with cystic fibrosis. J Clin Microbiol 41, 3415–3418.[CrossRef]
   [Google Scholar]